Harvard Catalyst Profiles

Princeton University	B.S.E	06/2011	Electrical Engineering
Duke University School of Medicine	M.D.	05/2017	Medicine
Massachusetts General Hospital	Resident	06/2021	Internal Medicine-Pediatrics
Dana-Farber Cancer Institute	Fellow	06/2023	Medical Oncology

I am a Physician in the Sarcoma Center of the Department of Medical Oncology at Dana-Farber Cancer Institute (DFCI), an Associate Physician at Brigham & Women’s Hospital (BWH), and an Instructor in Medicine at Harvard Medical School (HMS).

I am a board-certified medical oncologist with expertise in caring for patients with bone and soft tissue sarcomas, a rare disease comprising <1% of all adult cancers. I work closely with specialized surgeons, radiation oncologists, pathologists, and radiologists to provide holistic, multidisciplinary care to adult and adolescent/young adult (AYA) patients from across the world. I am a sub-investigator on all clinical trials in the Dana-Farber Sarcoma Center, and provide regular clinical and operational guidance to our current and future research efforts. Nationally, I serve as a member of the National Cancer Institute (NCI) PDQ Adult Treatment Editorial Board, in which I provide editorial guidance to sections relevant to sarcoma management.

I am also a board-certified internist and pediatrician with expertise in supporting the physical, emotional, and socioeconomic needs of adolescents and young adults (AYA) facing cancer. I hold leadership positions in national organizations focused on advocating for AYAs. I serve on the Board of Directors of the Adolescent and Young Adult Cancer Coalition (AYACC), the AYA Working Group of the Alliance for Clinical Trials in Oncology (Alliance), and the Steering Committee for the AYA Cancer Northeast Regional Network. I am involved in several local/institutional efforts to support AYAs as well.

I am an Affiliated Faculty in the Division of Population Sciences, McGraw-Patterson Center for Population Sciences. I am interested in leveraging novel technologies and artificial intelligence to improve cancer care, research, and outcomes. I am conducting patient engagement research as part of the Leiomyosarcoma (LMS) and Osteosarcoma (OS) Projects, both supported by the White House Cancer Moonshot.

Finally, I am a published essayist with passion for creative and reflective writing in medicine. I have previously developed institutional narrative medicine programs with Suzanne Koven, MGH's writer-in-residence, and I plan to continue these efforts with both cancer providers and patients.